Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ee Chee Ren

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Nature Biotechnology|March 10, 2006
Know the enemyEe Chee Ren
Hepatology (Baltimore, Md.)|July 2, 2011
Novel poly (ADP-ribose) polymerase 1 binding motif in hepatitis B virus core promoter impairs DNA damage repairHui-Ling Ko, Ee-Chee Ren
Drug Discovery Today|April 22, 2009
Immunoinformatics: current trends and future directionsJoo Chuan Tong, Ee Chee Ren
Biomolecules|June 28, 2014
Functional Aspects of PARP1 in DNA Repair and TranscriptionHui Ling Ko, Ee Chee Ren
The International Journal of Biochemistry & Cell Biology|August 19, 2007
Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage responsePing Feng, Bei Wang, Ee Chee Ren
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2009
Redefining the p53 response elementBei Wang, Ziwei Xiao, Ee Chee Ren
Cell Reports|March 7, 2019
HNF4α Combinatorial Isoform Heterodimers Activate Distinct Gene Targets that Differ from Their Corresponding HomodimersHui Ling Ko, Ziyi Zhuo, Ee Chee Ren
Immunologic Research|March 22, 2012
Structural and functional distinctiveness of HLA-A2 allelic variantsKenneth Yuanxiang Chen, Jingxian Liu, Ee Chee Ren
Immunogenetics|December 10, 2015
KIR-HLA profiling shows presence of higher frequencies of strong inhibitory KIR-ligands among prognostically poor risk AML patientsMeixin Shen, Yeh-Ching Linn, Ee-Chee Ren
Journal of Hepatology|January 22, 2009
LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinomaBei Wang, Ping Feng, Ziwei Xiao, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Nature Biotechnology|March 10, 2006
Know the enemyEe Chee Ren
Hepatology (Baltimore, Md.)|July 2, 2011
Novel poly (ADP-ribose) polymerase 1 binding motif in hepatitis B virus core promoter impairs DNA damage repairHui-Ling Ko, Ee-Chee Ren
Drug Discovery Today|April 22, 2009
Immunoinformatics: current trends and future directionsJoo Chuan Tong, Ee Chee Ren
Biomolecules|June 28, 2014
Functional Aspects of PARP1 in DNA Repair and TranscriptionHui Ling Ko, Ee Chee Ren
The International Journal of Biochemistry & Cell Biology|August 19, 2007
Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage responsePing Feng, Bei Wang, Ee Chee Ren
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2009
Redefining the p53 response elementBei Wang, Ziwei Xiao, Ee Chee Ren
Cell Reports|March 7, 2019
HNF4α Combinatorial Isoform Heterodimers Activate Distinct Gene Targets that Differ from Their Corresponding HomodimersHui Ling Ko, Ziyi Zhuo, Ee Chee Ren
Immunologic Research|March 22, 2012
Structural and functional distinctiveness of HLA-A2 allelic variantsKenneth Yuanxiang Chen, Jingxian Liu, Ee Chee Ren
Immunogenetics|December 10, 2015
KIR-HLA profiling shows presence of higher frequencies of strong inhibitory KIR-ligands among prognostically poor risk AML patientsMeixin Shen, Yeh-Ching Linn, Ee-Chee Ren
Journal of Hepatology|January 22, 2009
LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinomaBei Wang, Ping Feng, Ziwei Xiao, et al.
Pageof 7